Logo image of DATS

DATCHAT INC (DATS) Stock Fundamental Analysis

NASDAQ:DATS - Nasdaq - US23816M2061 - Common Stock - Currency: USD

2.85  -0.13 (-4.36%)

Premarket: 2.93 +0.08 (+2.81%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DATS. DATS was compared to 284 industry peers in the Software industry. DATS has a great financial health rating, but its profitability evaluates not so good. DATS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

DATS had negative earnings in the past year.
DATS had a negative operating cash flow in the past year.
DATS had negative earnings in each of the past 5 years.
In the past 5 years DATS always reported negative operating cash flow.
DATS Yearly Net Income VS EBIT VS OCF VS FCFDATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -107.38%, DATS is doing worse than 91.67% of the companies in the same industry.
DATS's Return On Equity of -95.42% is on the low side compared to the rest of the industry. DATS is outperformed by 77.17% of its industry peers.
Industry RankSector Rank
ROA -107.38%
ROE -95.42%
ROIC N/A
ROA(3y)-91.27%
ROA(5y)-651.68%
ROE(3y)-96.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DATS Yearly ROA, ROE, ROICDATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -2K -4K -6K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DATS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DATS Yearly Profit, Operating, Gross MarginsDATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 -200K -400K -600K -800K -1M

7

2. Health

2.1 Basic Checks

DATS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DATS has less shares outstanding
There is no outstanding debt for DATS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DATS Yearly Shares OutstandingDATS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 500K 1M 1.5M 2M
DATS Yearly Total Debt VS Total AssetsDATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

DATS has an Altman-Z score of -26.57. This is a bad value and indicates that DATS is not financially healthy and even has some risk of bankruptcy.
DATS has a worse Altman-Z score (-26.57) than 94.57% of its industry peers.
DATS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -26.57
ROIC/WACCN/A
WACC14.09%
DATS Yearly LT Debt VS Equity VS FCFDATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M -5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 13.20 indicates that DATS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 13.20, DATS belongs to the top of the industry, outperforming 97.83% of the companies in the same industry.
DATS has a Quick Ratio of 13.20. This indicates that DATS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 13.20, DATS belongs to the best of the industry, outperforming 97.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.2
Quick Ratio 13.2
DATS Yearly Current Assets VS Current LiabilitesDATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.01% over the past year.
Looking at the last year, DATS shows a very negative growth in Revenue. The Revenue has decreased by -98.66% in the last year.
EPS 1Y (TTM)51.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.3%
Revenue 1Y (TTM)-98.66%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DATS Yearly Revenue VS EstimatesDATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 10K 20K 30K 40K
DATS Yearly EPS VS EstimatesDATS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

DATS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DATS Price Earnings VS Forward Price EarningsDATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DATS Per share dataDATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DATS!.
Industry RankSector Rank
Dividend Yield N/A

DATCHAT INC

NASDAQ:DATS (2/20/2025, 8:09:38 PM)

Premarket: 2.93 +0.08 (+2.81%)

2.85

-0.13 (-4.36%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-25 2022-11-25/bmo
Earnings (Next)N/A N/A
Inst Owners2.16%
Inst Owner Change17.23%
Ins Owners5.86%
Ins Owner Change0%
Market Cap12.00M
Analysts0
Price TargetN/A
Short Float %4.89%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19045.24
P/FCF N/A
P/OCF N/A
P/B 1.96
P/tB 1.96
EV/EBITDA N/A
EPS(TTM)-2.58
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.41
FCFYN/A
OCF(TTM)-1.4
OCFYN/A
SpS0
BVpS1.45
TBVpS1.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -107.38%
ROE -95.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-91.27%
ROA(5y)-651.68%
ROE(3y)-96.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.2
Quick Ratio 13.2
Altman-Z -26.57
F-Score4
WACC14.09%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.3%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-98.66%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y47.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.22%
OCF growth 3YN/A
OCF growth 5YN/A